Peter Greenleaf

AUPH

Peter Greenleaf serves as Chief Executive Officer at Aurinia Pharmaceuticals Inc. (AUPH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$54.9K

Total Sells

6 trades

$7.23M

Net Position

Net Seller

$7.18M

Companies Traded

AUPH

Active Period

May 2021 – Feb 2026

7 total trades

Most Recent

Sell AUPH

Feb 20, 2026 · $1.44M

Peter Greenleaf's Insider Trading at Aurinia Pharmaceuticals Inc. (AUPH)

Buys

1 · $54.9K

Sells

6 · $7.23M

Total Shares Bought

5,125

Total Shares Sold

742,679

AUPH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Feb 20, 2026↗	Sell	100,171	$14.40	$1.44M
Jan 2, 2026↗	Sell	113,169	$15.95	$1.81M
Feb 28, 2025↗	Sell	360,540	$7.96	$2.87M
Mar 6, 2024↗	Sell	126,981	$5.60	$711.1K
Mar 2, 2023↗	Sell	32,750	$8.94	$292.8K
Mar 2, 2022↗	Sell	9,068	$12.01	$108.9K
May 11, 2021↗	Buy	5,125	$10.71	$54.9K